Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits  Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa.

Published byAlp Cevdet Modified over 5 years ago

Similar presentations

Presentation on theme: "Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits  Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa."— Presentation transcript:

1 Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits  Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa Kocakulak, PhD, Tamer Sari, BSc, Cem Yorgancioglu, MD, Yaman Zorlutuna, MD  The Annals of Thoracic Surgery  Volume 74, Issue 3, Pages (September 2002) DOI: /S (02)

2 Fig 1 Trend in hematologic variables throughout the five time periods of the study. (A) White blood cell (WBC) count, (B) platelet count, and (C) fibrinogen levels. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05, group 1 [□] versus group 2 [■]). The Annals of Thoracic Surgery  , DOI: ( /S (02) )

3 Fig 2 Trend in (A) serum protein and (B) serum albumin levels throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05, group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery  , DOI: ( /S (02) )

4 Fig 3 Serum interleukin-6 (IL-6) levels throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.01, group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery  , DOI: ( /S (02) )

5 Fig 4 Serum levels of (A) complement fragment C3a and (B) complement fragment C4d throughout the five time periods of the study. (CPB = cardiopulmonary bypass; ICU = intensive care unit; ∗p < 0.05 [C3a], group 1 [□] versus group 2 [■]; ∗ = p < 0.01 [C4d], group 1 [□] versus group 2 [■].) The Annals of Thoracic Surgery  , DOI: ( /S (02) )

Download ppt "Clinical performance and biocompatibility of poly(2-methoxyethylacrylate)—coated extracorporeal circuits  Serdar Gunaydin, MD, Bora Farsak, MD, Mustafa."

Similar presentations

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass  Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,

The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass  Russell E Anderson, MD, PhD, Lars-Olof Hansson, MD, PhD,
Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial  Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,

Stress-Dose Corticosteroid Versus Placebo in Neonatal Cardiac Operations: A Randomized Controlled Trial  Pertti K. Suominen, MD, PhD, Juho Keski-Nisula,
Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.

Antithrombin Administration in Patients With Low Antithrombin Values After Cardiac Surgery: A Randomized Controlled Trial  Domenico Paparella, MD, Crescenzia.
Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia  Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.
Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.

Changes in cysteinyl leukotrienes during and after cardiac surgery with cardiopulmonary bypass in patients with and without chronic obstructive pulmonary.
Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation  Anno Diegeler, MD, Robert Hirsch, MD, Felix Schneider,

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation  Anno Diegeler, MD, Robert Hirsch, MD, Felix Schneider,
Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting  Y.John Gu, Massimo A Mariani, Willem.

Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting  Y.John Gu, Massimo A Mariani, Willem.
Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura

Coronary Artery Bypass Grafting in Immune Thrombocytopenic Purpura
Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery  C.A. Rogers, S. Stoica,

Randomized trial of near-infrared spectroscopy for personalized optimization of cerebral tissue oxygenation during cardiac surgery  C.A. Rogers, S. Stoica,
Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass  Oddvar Moen, MD, Kolbjørn Høgåsen,

Attenuation of Changes in Leukocyte Surface Markers and Complement Activation With Heparin-Coated Cardiopulmonary Bypass  Oddvar Moen, MD, Kolbjørn Høgåsen,
Outcome After Rewarming From Accidental Hypothermia by Use of Extracorporeal Circulation  Øyvind Sverre Svendsen, MD, PhD, Ketil Grong, MD, PhD, Knut.

Outcome After Rewarming From Accidental Hypothermia by Use of Extracorporeal Circulation  Øyvind Sverre Svendsen, MD, PhD, Ketil Grong, MD, PhD, Knut.
Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values  Marco Ranucci, MD, Valeria.

Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values  Marco Ranucci, MD, Valeria.
Extracorporeal Membrane Oxygenation in Primary Graft Failure After Heart Transplantation  Silvana F. Marasco, FRACS, Matthew Vale, PhD, Vince Pellegrino,

Extracorporeal Membrane Oxygenation in Primary Graft Failure After Heart Transplantation  Silvana F. Marasco, FRACS, Matthew Vale, PhD, Vince Pellegrino,
A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,

A Closed Perfusion System With Heparin Coating and Centrifugal Pump Improves Cardiopulmonary Bypass Biocompatibility in Elderly Patients  Lena Lindholm,
Philip J Wolfson, MD  The Annals of Thoracic Surgery 

Philip J Wolfson, MD  The Annals of Thoracic Surgery 
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Richard P. Whitlock, MD, Mark.

Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K  Richard P. Whitlock, MD, Mark.
Minimally Invasive Extracorporeal Bypass in Minimally Invasive Heart Valve Operations: A Prospective Randomized Trial  Hardy Baumbach, MD, Christian J.

Minimally Invasive Extracorporeal Bypass in Minimally Invasive Heart Valve Operations: A Prospective Randomized Trial  Hardy Baumbach, MD, Christian J.
P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J

P. W. Boonstra, MD, PhD, Y. J. Gu, MD, PhD, C. Akkerman, BSc, J
Cerebrospinal Fluid Markers of Brain Injury, Inflammation, and Blood-Brain Barrier Dysfunction in Cardiac Surgery  Björn Reinsfelt, MD, PhD, Sven-Erik.

Cerebrospinal Fluid Markers of Brain Injury, Inflammation, and Blood-Brain Barrier Dysfunction in Cardiac Surgery  Björn Reinsfelt, MD, PhD, Sven-Erik.
Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants  Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants  Takaaki Suzuki, MD, Toyoki Fukuda, MD, Tsutomu Ito, MD,

Similar presentations

Ads by Google